Unraveling Key Chloroquine Resistance-Associated Alleles Among Plasmodium falciparum Isolates in South Darfur State, Sudan Twelve Years After Drug Withdrawal
Abdalmoneim Magboul,Bakri YM Nour,Abdelhakam Tamomh,Rashad Abdul-Ghani,Sayed Albushra,Hanan Eltahir
DOI: https://doi.org/10.2147/idr.s439875
2024-01-24
Infection and Drug Resistance
Abstract:Abdalmoneim M Magboul, 1 Bakri YM Nour, 2 Abdelhakam G Tamomh, 1 Rashad Abdul-Ghani, 3, 4 Sayed Mustafa Albushra, 5 Hanan Babiker Eltahir 6 1 Department of Parasitology & Medical Entomology, Faculty of Medical Laboratory Sciences, University of El Imam El Mahdi, Kosti, Sudan; 2 Department of Parasitology, Faculty of Medical Laboratory Sciences, University of Gezira, Wad Madani, Sudan; 3 Department of Medical Parasitology, Faculty of Medicine and Health Sciences, Sana'a University, Sana'a, Yemen; 4 Tropical Disease Research Center, Faculty of Medicine and Health Sciences, University of Science and Technology, Sana'a, Yemen; 5 Department of Internal Medicine, Faculty of Medicine, University of Gezira, Wad Madani, Sudan; 6 Department of Biochemistry, Faculty of Medicine, University of El Imam El Mahdi, Kosti, Sudan Correspondence: Abdelhakam G Tamomh, Email ; Background: Due to the increasing resistance of Plasmodium falciparum to chloroquine (CQ) in Sudan, a shift from CQ to artesunate combined with sulfadoxine/pyrimethamine as a first-line treatment for uncomplicated falciparum malaria was adopted in 2004. This study aimed to determine the frequency distribution of K76T and N86Y mutations in P. falciparum chloroquine resistance transporter ( pfcrt ) and P. falciparum multidrug resistance 1 ( pfmdr1 ) genes as key markers of resistance to CQ among P. falciparum isolates from patients in Nyala district of South Darfur state, west of Sudan. Methods: A descriptive, cross-sectional study was conducted among 75 P. falciparum isolates from Sudanese patients diagnosed with falciparum malaria mono-infection. Parasite DNA was extracted from dried blood spots and amplified using a nested polymerase chain reaction (PCR). Then, restriction fragment length polymorphism (RFLP) was used to detect the genetic polymorphisms in codons 76 of pfcrt and 86 of pfmdr1 . PCR-RFLP products were analyzed using 1.5% gel electrophoresis to identify the genetic polymorphisms in the studied codons. The wild-type (pfcrt K76 and pfmdr1 N86), mutant ( pfcrt 76T and pfmdr1 86Y) and mixed-type ( pfcrt K76T and pfmdr1 N86Y) alleles were expressed as frequencies and proportions. Results: The wild-type pfcrt K76 allele was observed among 34.7% of isolates and the mutant 76T allele among 20% of isolates, while the mixed-type K76T allele was observed among 45.3% of isolates. On the other hand, 54.7% of isolates harbored the wild-type pfmdr1 N86 allele and 5.3% of isolates had the mutant 86Y allele, while the mixed-type N86Y allele was observed among 40% of isolates. Conclusion: The key molecular markers associated with CQ resistance ( pfcrt 76T and pfmdr1 86Y) are still circulating in high frequency among P. falciparum isolates in South Darfur state, about twelve years after the official withdrawal of the drug as a treatment for uncomplicated falciparum malaria. Keywords: chloroquine, drug resistance, molecular markers, pfcrt , pfmdr1 , Sudan Sudan accounted for an estimated 41% of the malaria cases in the Eastern Mediterranean Region (EMR) of the World Health Organization (WHO) in 2022, 1 with about 8 million suspected cases and 1.4 million confirmed cases. Malaria in the country is predominantly caused by Plasmodium falciparum (80.5%), followed by Plasmodium vivax (9.2%). 1 The entire population is at risk of malaria, with approximately 87% being at high risk. 1 Malaria endemicity is primarily low to moderate in the country's northern, eastern and western states. 2 According to the last Malaria Indicator Survey (MIS) in 2016, the overall malaria prevalence in Sudan is 5.9%. 3 The prevalence varies across different regions of the country. In the states of Khartoum, Red Sea, Northern and River Nile, it is less than 1%, while it exceeds 20% in Central Darfur state. 3 The prevalence is around or above 10% in the states of South and West Darfur, Blue Nile and South Kordofan. 3 In South Darfur state, malaria transmission is largely mesoendemic, with pockets of hyperendemicity. 4 Chloroquine (CQ) has been used for treating falciparum malaria for more than four decades. 5 In the late 1970s, CQ sensitivity was reported among more than 99% of Sudanese patients infected with P. falciparum . 6 However, P. falciparum was resistant to CQ in 42% of patients in an in-vivo study in eastern Sudan in the late 1980s. 7 Since then, CQ resistance has -Abstract Truncated-
pharmacology & pharmacy,infectious diseases